Company intelligence / Profile preview

Izertis

Ownership: Private
Employees: ~1868
Development stage: Other

Overview

Izertis is a Spanish technology consultancy founded in 1996 that provides digital transformation services—including software engineering/cloud/cybersecurity/data intelligence—to clients across many industries such as finance/banking/public sector and also serves the pharma and healthcare sectors with IT solutions. The company does not develop drugs or own therapeutic pipelines—it enables operational efficiency for its clients through technology rather than direct biomedical innovation. It trades publicly on the Madrid Stock Exchange under ticker IZER.

Industry: Consulting

Partnerships

Provides digital transformation and change management for pharmaceutical industry clients; no major biotech/pharma R&D partnerships disclosed

Beyond the preview

Go deeper on Izertis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Izertis.

Explore the full profile